Screener
BioLife Solutions BLFS EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from BioLife Solutions’s reported figures.
The source filing: BioLife Solutions’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:22 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054355
FAQ
- What is BioLife Solutions's EBITDA?
- BioLife Solutions (BLFS) reported EBITDA of $2.11M in Q2 2026.
- How has BioLife Solutions's EBITDA changed year-over-year?
- BioLife Solutions's EBITDA increased by 113.6% year-over-year, from -$15.45M to $2.11M.
- What is the long-term trend for BioLife Solutions's EBITDA?
- Over 2 years (2021 to 2025), BioLife Solutions's EBITDA has grown at a -31.1% compound annual growth rate (CAGR), from -$30.5M to -$14.46M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about BioLife Solutions's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude